Invention Grant
- Patent Title: Stabilized pharmaceutical formulations comprising antineoplastic compounds
- Patent Title (中): 包含抗肿瘤化合物的稳定药物制剂
-
Application No.: US13826807Application Date: 2013-03-14
-
Publication No.: US08974811B2Publication Date: 2015-03-10
- Inventor: Mahmoud S. AlSwisi , Mahmoud A. A. Ghannam
- Applicant: Mahmoud S. AlSwisi , Mahmoud A. A. Ghannam
- Applicant Address: JO
- Assignee: Hikma Pharmaceuticals
- Current Assignee: Hikma Pharmaceuticals
- Current Assignee Address: JO
- Agency: Merchant & Gould P.C.
- Main IPC: A61F2/02
- IPC: A61F2/02 ; A61K47/02 ; A61K9/00 ; A61K47/12 ; A61K9/08 ; A61K9/19 ; A61K31/4188 ; A61K31/495
Abstract:
The present invention relates to stabilized pharmaceutical formulations prepared from solutions comprising an antineoplastic compound having a cyclic or non-cyclic hydrazine, triazine, or tetrazine group, or a pharmaceutically acceptable salt thereof, and a stabilizer, wherein the stabilizer is an antioxidant and/or more susceptible to nucleophilic attack than the antineoplastic compound.
Public/Granted literature
- US20140275195A1 STABILIZED PHARMACEUTICAL FORMULATIONS COMPRISING ANTINEOPLASTIC COMPOUNDS Public/Granted day:2014-09-18
Information query
IPC分类:
